Desert King
  • Home
  • About Us
  • Raw Materials
    • Quillaja Management
    • Yucca Management
    • Jojoba Management
  • Lines of Business
    • Pharmaceuticals
    • Animal Nutrition and Health
    • Food and Beverages
    • Personal Care and Cosmetics
    • Agriculture
    • Environment and Mining
  • Quality
  • News
  • Contact
  • English
  • Spanish
The Natural Choice The Natural Choice The Natural Choice The Natural Choice
  • Home
  • About Us
  • Raw Materials
    • Quillaja Management
    • Yucca Management
    • Jojoba Management
  • Lines of Business
    • Pharmaceuticals
    • Animal Nutrition and Health
    • Food and Beverages
    • Personal Care and Cosmetics
    • Agriculture
    • Environment and Mining
  • Quality
  • News
  • Contact
  • English
  • Spanish

Photo Albums

0
By Desert King
In Publications
Posted 24 February, 2026

Defining the Future of Quillaja Supply: Scale, Stability, and Sustainability

Ensuring a stable, renewable supply of natural ingredients has become a critical priority for industries that rely on plant-based solutions. At Desert King®, this challenge is addressed through a [...]

READ MORE
 Desert King Advances Clean Beauty Through Quillaja-Based Cosmetic Ingredients
0
By Desert King
In Publications
Posted 24 February, 2026

Desert King Advances Clean Beauty Through Quillaja-Based Cosmetic Ingredients

As the cosmetic and personal care industry continues to raise standards for ingredient origin, transparency, and performance, Desert King® reinforces its position as a global leader in botanical [...]

READ MORE
 Poultry Production: How botanical science is shaping modern performance
0
By Matias Bobadilla
In Publications
Posted 12 February, 2026

Poultry Production: How botanical science is shaping modern performance

The poultry industry is evolving rapidly. Producers worldwide are under pressure to maintain performance while reducing routine antibiotic use, improving sustainability, and meeting higher [...]

READ MORE
 Enzymology and Structural Basis of Glycosyltransferases Involved in Saponin C28 Carboxylic Acid O‑d‑Fucosylation
0
By David Romero
In Scientific Papers
Posted 11 February, 2026

Enzymology and Structural Basis of Glycosyltransferases Involved in Saponin C28 Carboxylic Acid O‑d‑Fucosylation

Hudson, G.A., et al. Enzymology and Structural Basis of Glycosyltransferases Involved in Saponin C28 Carboxylic Acid OdFucosylation. JACS Au, 2025 Nov 24, 5(12):6011- 6024. PMID: 41450652   [...]

READ MORE
 QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants
0
By David Romero
In Scientific Papers
Posted 11 February, 2026

QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants

Hu, Y., et al. QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants. Eur J Med Chem, 2026 Jan 5, 301:118223. PMID: 41046625   [...]

READ MORE
 TB vaccine development: monitoring international patent filings to anticipate access challenges
0
By David Romero
In Scientific Papers
Posted 11 February, 2026

TB vaccine development: monitoring international patent filings to anticipate access challenges

Pignataro, M.F., et al. TB vaccine development: monitoring international patent filings to anticipate access challenges. Front Public Health, 2026 Jan 16, 13:1726153. PMID: 41626371   This [...]

READ MORE
 Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice
0
By David Romero
In Scientific Papers
Posted 10 February, 2026

Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice

Quan, Y., et al. Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice. Viruses, 2025 Dec 30, 18(1):53. PMID: 41600818   This study addresses the significant public health [...]

READ MORE
 Ferguson, M., et al. Immune persistence and safety of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial. Hum Vaccin Immunother, 2025 Dec, 21(1):2579335. PMID: 41194599
0
By Desert King
In Scientific Papers
Posted 19 January, 2026

Ferguson, M., et al. Immune persistence and safety of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial. Hum Vaccin Immunother, 2025 Dec, 21(1):2579335. PMID: 41194599

Respiratory syncytial virus (RSV) is a leading cause of respiratory illness across all age groups, particularly affecting infants, older adults, and individuals with chronic health conditions, [...]

READ MORE
 Rayens, E., et al. Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years. Clin Infect Dis, 2025 Dec 24, 81(5):e441-e445. PMID: 40795767
0
By Desert King
In Scientific Papers
Posted 19 January, 2026

Rayens, E., et al. Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years. Clin Infect Dis, 2025 Dec 24, 81(5):e441-e445. PMID: 40795767

Herpes zoster (shingles) and its complication, herpes zoster ophthalmicus (HZO), are associated with an increased risk of cardiovascular events such as heart attacks and strokes, especially in [...]

READ MORE
 Shrivastava, S., et al. ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates. NPJ Vaccines, 2025 Dec 19, PMID: 41419739
0
By Desert King
In Scientific Papers
Posted 19 January, 2026

Shrivastava, S., et al. ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates. NPJ Vaccines, 2025 Dec 19, PMID: 41419739

The development of an effective HIV-1 vaccine remains a global health priority due to the persistent high prevalence of HIV/AIDS despite advances in treatment and prevention strategies. While [...]

READ MORE

DESERT KING INTERNATIONAL
745 Main Street-
Chula Vista, CA, USA, 91911
+1 619 429 5222
info@desertking.com

DESERT KING CHILE
Avenida Industrial 1970
Quilpué, Chile, 2420505
+56 32 292 5020
info@desertking.cl

DESERT KING MEXICO
Camino Vecinal 11500-A
Tijuana B.C., México, 22664
+52 664 636 11 24
info@desertkingmexico.com

Privacy Policy
© 2025 Desert King. All Right Reserved

Start typing and press Enter to search